MRKR director files Form 3, reports no beneficial ownership
Marker Therapeutics (MRKR) filed a Form 3 reporting the initial beneficial ownership for a director as of 10/31/2025.
Rhea-AI Filing Summary
Marker Therapeutics (MRKR) filed a Form 3 reporting the initial beneficial ownership for a director as of 10/31/2025. The filing states that no securities are beneficially owned.
The form was signed by /s/ Julio C. Esquivel as attorney-in-fact for Kathryn Penkus Corzo, pursuant to a power of attorney dated October 15, 2025.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Marker Therapeutics (MRKR) file?
A Form 3, the initial statement of beneficial ownership for a reporting person.
Who is the reporting person on the MRKR Form 3?
The form pertains to a director; it was signed by /s/ Julio C. Esquivel as attorney-in-fact for Kathryn Penkus Corzo.
What is the event date on the MRKR Form 3?
The event date is 10/31/2025.
How many MRKR securities are reported as beneficially owned?
The filing states no securities are beneficially owned.
Who signed the MRKR Form 3 and under what authority?
It was signed by /s/ Julio C. Esquivel as attorney-in-fact under a power of attorney dated October 15, 2025.
What is the reporting person’s relationship to Marker Therapeutics?
The reporting person is a director.
AI-generated analysis. How Rhea-AI works. Not financial advice.